Table 4 Barriers to MOUD access by type of medication
From: The impact of the opioid crisis on U.S. state prison systems
Barriers to providing MOUD to everyone with an OUD in every prison | Type of Medication for OUD (MOUD)\1 | ||
|---|---|---|---|
Buprenorphine (n = 18) | Methadone (n = 18) | Naltrexone (n = 14) | |
The state lacks funds needed for the medical and clinical staff to support the provision of the medication | 67% | 67% | 43% |
The state lacks funds needed for resources to prevent diversion | 61% | 44% | 14% |
The state lacks funds to pay for the medication | 50% | 50% | 71% |
The state prefers more of an abstinence-based approach to treatment | 39% | 39% | 14% |
Regulations make it difficult to provide the medication | 33% | 61% | 14% |
Lack of access to training or technical assistance on its use | 22% | 11% | 21% |
Inadequate reimbursement rate | 17% | 6% | 0% |
There are not enough community providers of the medication to work with individuals following release | 11% | 33% | 29% |
The facilities lack necessary relationships with community MOUD providers | 11% | 28% | 29% |
People confined to state prisons do not want this type of medication | 6% | 6% | 36% |
Other | 11% | 28% | 21% |